TY - JOUR
T1 - Aggressive endoscopic therapy for pancreatic necrosis and pancreatic abscess
T2 - A new safe and effective treatment algorithm (videos)
AU - Seewald, Stefan
AU - Groth, Stefan
AU - Omar, Salem
AU - Imazu, Hiroo
AU - Seitz, Uwe
AU - De Weerth, Andreas
AU - Soetikno, Roy
AU - Zhong, Yan
AU - Sriram, Parupudi V.J.
AU - Ponnudurai, Ryan
AU - Sikka, Sanjay
AU - Thonke, Frank
AU - Soehendra, Nib
PY - 2005/7
Y1 - 2005/7
N2 - Background: Pancreatic necrosis and pancreatic abscess are severe complications of acute pancreatitis. Surgery is associated with significant morbidity and mortality in these critically ill patients. Endoscopic therapy has the potential to offer a safer and more effective alternative treatment modality. However, its role needs to be further investigated. Methods: This is a retrospective study of the outcome of consecutive patients with pancreatic necrosis and pancreatic abscess, all unfit to undergo surgery, who underwent a new aggressive endoscopic approach. The treatment includes (1) synchronous EUS-guided multiple transmural and/or transpapillary drainage procedures followed by balloon dilation of the cystogastrostoma or cystoduodenostoma, (2) daily endoscopic necrosectomy and saline solution lavage, and (3) sealing of pancreatic fistula by N-butyl-2-cyanoacrylate. Results: Pancreatic necrosis and pancreatic abscesses were successfully drained in 13 patients, thus avoiding emergency surgery as an initial treatment. Surgery was completely avoided in 9 patients over a median follow-up of 8.3 months (range 3-81 months). Surgery was combined with endoscopic therapy in one patient because of abscess extension into the right paracolic gutter, which was not manageable by endoscopic drainage. Because of the "disconnected-duct syndrome," two patients later developed recurrent pseudocysts and underwent elective surgery. Complications included minor bleeding after balloon dilation and necrosectomy in 4 cases, which were self limiting or controlled endoscopically. Conclusions: This aggressive endoscopic approach shows promising results. It expands the potential for endoscopic treatment in patients with pancreatic necrosis and/or pancreatic abscess.
AB - Background: Pancreatic necrosis and pancreatic abscess are severe complications of acute pancreatitis. Surgery is associated with significant morbidity and mortality in these critically ill patients. Endoscopic therapy has the potential to offer a safer and more effective alternative treatment modality. However, its role needs to be further investigated. Methods: This is a retrospective study of the outcome of consecutive patients with pancreatic necrosis and pancreatic abscess, all unfit to undergo surgery, who underwent a new aggressive endoscopic approach. The treatment includes (1) synchronous EUS-guided multiple transmural and/or transpapillary drainage procedures followed by balloon dilation of the cystogastrostoma or cystoduodenostoma, (2) daily endoscopic necrosectomy and saline solution lavage, and (3) sealing of pancreatic fistula by N-butyl-2-cyanoacrylate. Results: Pancreatic necrosis and pancreatic abscesses were successfully drained in 13 patients, thus avoiding emergency surgery as an initial treatment. Surgery was completely avoided in 9 patients over a median follow-up of 8.3 months (range 3-81 months). Surgery was combined with endoscopic therapy in one patient because of abscess extension into the right paracolic gutter, which was not manageable by endoscopic drainage. Because of the "disconnected-duct syndrome," two patients later developed recurrent pseudocysts and underwent elective surgery. Complications included minor bleeding after balloon dilation and necrosectomy in 4 cases, which were self limiting or controlled endoscopically. Conclusions: This aggressive endoscopic approach shows promising results. It expands the potential for endoscopic treatment in patients with pancreatic necrosis and/or pancreatic abscess.
UR - http://www.scopus.com/inward/record.url?scp=21544442065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=21544442065&partnerID=8YFLogxK
U2 - 10.1016/S0016-5107(05)00541-9
DO - 10.1016/S0016-5107(05)00541-9
M3 - Article
C2 - 15990825
AN - SCOPUS:21544442065
SN - 0016-5107
VL - 62
SP - 92
EP - 100
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 1
ER -